Vaxart, Inc Common Stock
VXRT Real Time Price USDRecent trades of VXRT by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by VXRT's directors and management
Government lobbying spending instances
-
$20,000 Jan 18, 2023 Issue: Health Issues
-
$80,000 Jan 18, 2023 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Oct 20, 2022 Issue: Health Issues
-
$80,000 Oct 17, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jul 20, 2022 Issue: Health Issues
-
$80,000 Jul 18, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$80,000 Apr 19, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Apr 18, 2022 Issue: Health Issues
-
$80,000 Jan 20, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jan 18, 2022 Issue: Health Issues
-
$20,000 Oct 23, 2021 Issue: Health Issues
-
$80,000 Oct 20, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jul 22, 2021 Issue: Health Issues
-
$80,000 Jul 20, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Apr 20, 2021 Issue: Health Issues
-
$80,000 Apr 20, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$50,000 Jan 21, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jan 20, 2021 Issue: Health Issues
-
$20,000 Oct 20, 2020 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Formulations for small intestinal delivery of rsv and norovirus antigens Sep. 06, 2022
-
Patent Title: Piperidine derivatives as human papilloma virus inhibitors May. 22, 2018
-
Patent Title: Chimeric adenoviral vectors Apr. 07, 2015
-
Patent Title: Chimeric adenoviral vectors Jul. 17, 2012
-
Patent Title: Chimeric adenoviral vectors Feb. 01, 2011
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of VXRT in WallStreetBets Daily Discussion
Recent insights relating to VXRT
Recent picks made for VXRT stock on CNBC
ETFs with the largest estimated holdings in VXRT
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view VXRT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.